Article info
PDFHepatology
Original article
Inhibition of histidine decarboxylase ablates the autocrine tumorigenic effects of histamine in human cholangiocarcinoma
- Correspondence to Dr Gianfranco Alpini, Scott & White Digestive Diseases Research Center, Central Texas Veterans Health Care System, Texas A&M Health Science Center College of Medicine, Olin E Teague Medical Center, 1901 South 1st Street, Bldg 205, 1R60, Temple, TX 76504, USA; galpini{at}tamu.edu
Citation
Inhibition of histidine decarboxylase ablates the autocrine tumorigenic effects of histamine in human cholangiocarcinoma
Publication history
- Revised June 28, 2011
- Accepted July 1, 2011
- First published August 26, 2011.
Online issue publication
October 26, 2017
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© 2012, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.